دورية أكاديمية
أعرض في EDS

Treated large posterior fossa vestibular schwannoma and meningioma: Hearing outcome and willingness-to-accept brain implant for unilateral deafness.

التفاصيل البيبلوغرافية
العنوان: Treated large posterior fossa vestibular schwannoma and meningioma: Hearing outcome and willingness-to-accept brain implant for unilateral deafness.
المؤلفون: Jiam NT; Department of Otolaryngology-Head and Neck Surgery University of California San Francisco California USA., Gillard DM; Department of Otolaryngology-Head and Neck Surgery University of California San Francisco California USA., Morshed RA; Department of Neurosurgery University of California San Francisco California USA., Bhutada AS; Virginia Tech Carilion School of Medicine Roanoke Virginia USA., Crawford ED; Department of Otolaryngology-Head and Neck Surgery University of California San Francisco California USA., Braunstein SW; Department of Radiation Oncology University of California San Francisco California USA., Henderson Sabes J; Department of Otolaryngology-Head and Neck Surgery University of California San Francisco California USA., Theodosopoulos PV; Department of Neurosurgery University of California San Francisco California USA., Cheung SW; Department of Otolaryngology-Head and Neck Surgery University of California San Francisco California USA.; Surgical Services, San Francisco Veterans Affairs Health Care System San Francisco California USA.
المصدر: Laryngoscope investigative otolaryngology [Laryngoscope Investig Otolaryngol] 2022 Oct 27; Vol. 7 (6), pp. 2057-2063. Date of Electronic Publication: 2022 Oct 27 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101684963 Publication Model: eCollection Cited Medium: Print ISSN: 2378-8038 (Print) Linking ISSN: 23788038 NLM ISO Abbreviation: Laryngoscope Investig Otolaryngol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Hoboken, NJ] : Wiley, [2016]-
مستخلص: Background/objective: To compare functional hearing and tinnitus outcomes in treated large (~ 3 cm) vestibular schwannoma (VS) and posterior fossa meningioma cohorts, and construct willingness-to-accept profiles for an experimental brain implant to treat unilateral hearing loss.
Methods: A two-way MANOVA model with two independent variables (tumor type; time from treatment) and three dependent variables (hearing effort of tumor ear; abbreviated Speech, Spatial, and Qualities of Hearing scale (SSQ12); Tinnitus Functional Index (TFI)) was used to analyze data from VS ( N  = 32) and meningioma ( N  = 50) patients who were treated at a tertiary care center between 2010 and 2020. A query to probe acceptance of experimental treatment for hearing loss relative to expected benefit was used to construct willingness-to-accept profiles.
Results: Tumor type was statistically significant on the combined dependent variables analysis ( F [3, 76] = 19.172, p  < .0005, Wilks' Λ = 0.569). Meningioma showed better outcome for hearing effort ( F [1, 76] = 14.632, p  < .0005) and SSQ12 ( F [1, 76] = 16.164, p  < .0005), but not for TFI ( F [1, 76] = 1.247, p  = .268) on univariate two-way ANOVA analyses. Superior hearing effort and SSQ12 indices in the short-term (< 2 years) persisted in the long-term (> 2 years) ( p  ≤ .017). At the 60% speech understanding level, 77% of respondents would accept an experimental brain implant.
Conclusion: Hearing outcome is better for posterior fossa meningioma compared to VS. Most patients with hearing loss in the tumor ear would consider a brain implant if the benefit level would be comparable to a cochlear implant.
Level of Evidence: 2.
Competing Interests: None.
(© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.)
References: Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2373-83. (PMID: 26498948)
J Clin Neurosci. 2005 May;12(4):503-6. (PMID: 15925797)
Otol Neurotol. 2020 Dec;41(10):e1178-e1184. (PMID: 32810009)
Front Oncol. 2020 Oct 23;10:579599. (PMID: 33194703)
Otol Neurotol. 2007 Jan;28(1):31-8. (PMID: 17195743)
PLoS One. 2020 May 5;15(5):e0232421. (PMID: 32369519)
JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):925-932. (PMID: 32857114)
J Neurooncol. 2022 Mar;157(1):165-176. (PMID: 35113287)
J Neurol Surg B Skull Base. 2019 Dec;80(6):632-639. (PMID: 31750050)
Ear Hear. 2020 Nov 05;42(3):654-661. (PMID: 33156124)
Am J Otol. 1993 Sep;14(5):423-33. (PMID: 8122702)
J Neurophysiol. 2014 Mar;111(5):1077-87. (PMID: 24335216)
ORL J Otorhinolaryngol Relat Spec. 2015;77(6):339-45. (PMID: 26418165)
Ear Hear. 2012 Mar-Apr;33(2):153-76. (PMID: 22156949)
Otol Neurotol. 2017 Feb;38(2):212-220. (PMID: 27898605)
Eur Arch Otorhinolaryngol. 2014 Aug;271(8):2119-26. (PMID: 24096818)
Otolaryngol Clin North Am. 2015 Jun;48(3):461-75. (PMID: 26043142)
J Am Acad Audiol. 1998 Aug;9(4):251-6. (PMID: 9733233)
Otol Neurotol. 2012 Jul;33(5):853-62. (PMID: 22664900)
Hear Res. 2015 Apr;322:212-23. (PMID: 25613994)
Front Neurol. 2021 Nov 04;12:760831. (PMID: 34803893)
Otol Neurotol. 2014 Jan;35(1):43-51. (PMID: 24335931)
Stat Med. 1999 Sep 15-30;18(17-18):2479-92. (PMID: 10474154)
Oncogene. 2011 May 19;30(20):2333-44. (PMID: 21242963)
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):58-69. (PMID: 33151295)
Laryngoscope. 2011 Jul;121(7):1548-54. (PMID: 21671232)
Otol Neurotol. 2014 Dec;35(10):1844-51. (PMID: 25325841)
Radiographics. 2018 Jan-Feb;38(1):94-106. (PMID: 29320320)
Asian J Neurosurg. 2019 Jan-Mar;14(1):154-161. (PMID: 30937027)
N Engl J Med. 2021 Jul 22;385(4):381-382. (PMID: 34289290)
Otol Neurotol. 2010 Feb;31(2):216-9. (PMID: 19887974)
J Neurosurg Sci. 2003 Sep;47(3):129-35; discussion 135. (PMID: 14618125)
J Laryngol Otol. 1975 Nov;89(11):1161-4. (PMID: 1081563)
J Neurooncol. 2010 Sep;99(3):307-14. (PMID: 20821343)
J Clin Neurosci. 2010 Jan;17(1):107-12. (PMID: 20004580)
Cochlear Implants Int. 2016 Jul;17(4):172-177. (PMID: 27691934)
Commun Stat Theory Methods. 2018;47(22):5418-5434. (PMID: 30983686)
J Neurosurg. 2002 Apr;96(4):796-800. (PMID: 11990824)
PLoS One. 2021 Oct 13;16(10):e0257447. (PMID: 34644322)
Eur Arch Otorhinolaryngol. 2016 Jan;273(1):27-35. (PMID: 25537817)
Neurosurgery. 2005 Jul;57(1):77-90; discussion 77-90. (PMID: 15987543)
J Neurosurg. 2011 Oct;115(4):827-34. (PMID: 21761973)
Int J Audiol. 2013 Jun;52(6):409-12. (PMID: 23651462)
Biomed Res Int. 2016;2016:4980562. (PMID: 27747231)
Neurosurgery. 1988 Mar;22(3):573-5. (PMID: 3258964)
Laryngoscope. 2005 Nov;115(11):1974-8. (PMID: 16319608)
Oncogene. 2020 Aug;39(32):5421-5429. (PMID: 32616891)
Ear Hear. 2019 Jul/Aug;40(4):766-781. (PMID: 30358655)
Front Neurosci. 2021 Dec 22;15:632822. (PMID: 35002596)
Otolaryngol Head Neck Surg. 1993 Dec;109(6):1025-9. (PMID: 8265185)
Otol Neurotol. 2009 Aug;30(5):614-8. (PMID: 19546832)
فهرسة مساهمة: Keywords: hearing; meningioma; tinnitus; vestibular schwannoma; willingness‐to‐accept
تواريخ الأحداث: Date Created: 20221222 Latest Revision: 20221223
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9764787
DOI: 10.1002/lio2.957
PMID: 36544942
قاعدة البيانات: MEDLINE
الوصف
تدمد:2378-8038
DOI:10.1002/lio2.957